Lord Abbett Health Care Fund Class A (LHCAX)
| Fund Assets | 8.70M |
| Expense Ratio | 1.03% |
| Min. Investment | $1,500 |
| Turnover | 91.00% |
| Dividend (ttm) | 0.03 |
| Dividend Yield | 0.14% |
| Dividend Growth | -44.54% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 2, 2025 |
| Previous Close | 22.07 |
| YTD Return | -0.84% |
| 1-Year Return | 12.70% |
| 5-Year Return | 11.46% |
| 52-Week Low | 17.53 |
| 52-Week High | 24.98 |
| Beta (5Y) | 0.78 |
| Holdings | 60 |
| Inception Date | Jul 31, 2019 |
About LHCAX
Lord Abbett Health Care Fund Class A is an actively managed mutual fund focused on achieving long-term capital appreciation by investing primarily in companies within the health care sector. The fund allocates at least 80% of its net assets to equity and equity-related securities of health care-related firms, making it a targeted vehicle for gaining exposure to the diverse and evolving health care industry. Its portfolio typically includes leading pharmaceutical, biotechnology, and medical device companies, with notable holdings in firms such as Eli Lilly, Novo Nordisk, and Intuitive Surgical. This fund is designed to participate in the growth dynamics of the global health care sector, addressing areas such as drug development, diagnostic tools, and advanced medical technologies. It is categorized as a mid-growth fund and holds a diversified mix of about 58 companies, with approximately 39.5% of assets in its top ten positions. While the fund offers access to a sector with significant long-term growth potential driven by innovation and demographics, it features a front-end sales charge and a relatively high expense ratio compared to its peers. Lord Abbett Health Care Fund Class A plays a specialized role for investors seeking sector-specific exposure within the broader equity markets.
Performance
LHCAX had a total return of 12.70% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.65%.
Top 10 Holdings
36.77% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.85% |
| argenx SE | ARGX | 4.02% |
| Gilead Sciences, Inc. | GILD | 3.51% |
| AstraZeneca PLC | AZN | 3.49% |
| Tarsus Pharmaceuticals, Inc. | TARS | 3.16% |
| Natera, Inc. | NTRA | 3.00% |
| Guardant Health, Inc. | GH | 2.91% |
| Cencora, Inc. | COR | 2.74% |
| EssilorLuxottica Société anonyme | EL | 2.66% |
| ABIVAX Société Anonyme | ABVX | 2.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 2, 2025 | $0.0335 | Dec 2, 2025 |
| Nov 26, 2024 | $0.0604 | Nov 26, 2024 |
| Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
| Nov 24, 2020 | $2.3119 | Nov 24, 2020 |